Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析

◆英語タイトル:Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDING347582FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Ingredients
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chenguang Biotech Group Co Ltd (300138) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chenguang Biotech Group Co Ltd (Chenguang) manufactures, supplies, and exports agricultural products and herb extracts. The company’s product portfolio comprises paprika oleoresin, marigold oleoresin, refined cottonseed oil, cottonseed oil, grape seed oil, walnut oil, dephenolized cottonseed protein, flaxseed oil, natural lutein, safflower seed oil and turmeric. It also offers capsicum oleoresins, sichuan pepper oil, pepper oleoresin, ginger extract, cumin oil, lycopene, lutein, green coffee bean extract, grape seed extract, curcumin, inulin, and stevioside. Chenguang serves to food, beverages, animal feed, pharmaceutical, cosmetics and healthcare industries. It exports to Europe, the Americas, Australia, Japan, South Korea, South Asia, Southeast Asia, and Africa. The company is headquartered in Quzhou County, Hebei, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Chenguang Biotech Group Co Ltd – Key Facts
Chenguang Biotech Group Co Ltd – Key Employees
Chenguang Biotech Group Co Ltd – Major Products and Services
Chenguang Biotech Group Co Ltd – History
Chenguang Biotech Group Co Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Chenguang Biotech Group Co Ltd – Business Description
Chenguang Biotech Group Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Chenguang Biotech Group Co Ltd – Strengths
Chenguang Biotech Group Co Ltd – Weaknesses
Chenguang Biotech Group Co Ltd – Opportunities
Chenguang Biotech Group Co Ltd – Threats
Chenguang Biotech Group Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Chenguang Biotech Group Co Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chenguang Biotech Group Co Ltd, Key Facts
Chenguang Biotech Group Co Ltd, Key Employees
Chenguang Biotech Group Co Ltd, Major Products and Services
Chenguang Biotech Group Co Ltd, History
Chenguang Biotech Group Co Ltd, Key Competitors
Chenguang Biotech Group Co Ltd, Ratios based on current share price
Chenguang Biotech Group Co Ltd, Annual Ratios
Chenguang Biotech Group Co Ltd, Annual Ratios (Cont...1)
Chenguang Biotech Group Co Ltd, Annual Ratios (Cont...2)
Chenguang Biotech Group Co Ltd, Interim Ratios
Chenguang Biotech Group Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Viacom, Inc.:企業の戦略・SWOT・財務情報
    Viacom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Viacom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • YO Sushi UK Ltd:企業の戦略・SWOT・財務情報
    YO Sushi UK Ltd - Strategy, SWOT and Corporate Finance Report Summary YO Sushi UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HiQ International AB (HIQ):企業の財務・戦略的SWOT分析
    Summary HiQ International AB (HiQ International) is a technology and communication company that offers management consultancy services. The company offers communication solutions, development of software, and business-critical IT systems. It provides services in the areas of telecom media, gaming an …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • International Games System Co Ltd:企業の戦略・SWOT・財務分析
    International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report Summary International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Korea East-West Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • F. Hoffmann-La Roche Ltd:企業の戦略・SWOT・財務情報
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, in …
  • Secom Co Ltd.:企業の戦略・SWOT・財務分析
    Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Banca Del Ceresio SA:企業の戦略・SWOT・財務情報
    Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report Summary Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TreeHouse Foods, Inc.:企業の戦略・SWOT・財務情報
    TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報
    Summary APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. A …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Adacel Technologies Limited:企業の戦略・SWOT・財務情報
    Adacel Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Adacel Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cardia Inc-医療機器分野:企業M&A・提携分析
    Summary Cardia Inc (Cardia) is a medical device company that designs, manufactures, and markets transcatheter septal occluders for cardiac defect patients. The company’s products include ultrasept ASD, ultraseptLAA, ultraseptPFO, fontan occlude among others. Its UltraseptASD is used for the transven …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆